Universitat de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (32)

2023

  1. A human genome editing–based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features

    Blood, Vol. 142, Núm. 20, pp. 1752-1756

  2. Circulating miRNA expression in long-standing type 1 diabetes mellitus

    Scientific Reports, Vol. 13, Núm. 1

  3. DPPA3-HIF1α axis controls colorectal cancer chemoresistance by imposing a slow cell-cycle phenotype

    Cell Reports, Vol. 42, Núm. 8

  4. The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent

    Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895

2022

  1. Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies

    Journal of the National Cancer Institute, Vol. 114, Núm. 3, pp. 436-445

2021

  1. Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome

    Blood, Vol. 137, Núm. 7, pp. 994-999

  2. Integrative methylome-transcriptome analysis unravels cancer cell vulnerabilities in infant MLLrearranged B cell acute lymphoblastic leukemia

    Journal of Clinical Investigation, Vol. 131, Núm. 13

2019

  1. Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment

    Nucleic Acids Research, Vol. 47, Núm. 10, pp. 5016-5037

  2. Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program

    Acta Neuropathologica, Vol. 138, Núm. 6, pp. 1053-1074

  3. Natural history and cell of origin of TCF3-ZNF384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL

    Blood

2018

  1. Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis

    The Lancet Respiratory Medicine, Vol. 6, Núm. 10, pp. 771-781

  2. Epigenome-wide analysis reveals specific DNA hypermethylation of T cells during human hematopoietic differentiation

    Epigenomics, Vol. 10, Núm. 7, pp. 903-924

  3. Loss of 5hmC identifies a new type of aberrant DNA hypermethylation in glioma

    Human Molecular Genetics, Vol. 27, Núm. 17, pp. 3046-3059

2017

  1. DNA methylation changes in human lung epithelia cells exposed to multi-walled carbon nanotubes

    Nanotoxicology, Vol. 11, Núm. 7, pp. 857-870

  2. Generation and characterization of a human iPSC cell line expressing inducible Cas9 in the “safe harbor” AAVS1 locus

    Stem Cell Research, Vol. 21, pp. 137-140

2016

  1. Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency

    Stem Cell Reports, Vol. 7, Núm. 4, pp. 602-618

  2. Quantitative comparison of DNA methylation assays for biomarker development and clinical applications

    Nature Biotechnology, Vol. 34, Núm. 7, pp. 726-737

  3. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα

    Leukemia, Vol. 30, Núm. 3, pp. 674-682

2015

  1. H3K4me1 marks DNA regions hypomethylated during aging in human stem and differentiated cells

    Genome Research, Vol. 25, Núm. 1, pp. 27-40

2014

  1. Regulation of DNA methylation patterns by CK2-mediated phosphorylation of Dnmt3a

    Cell Reports, Vol. 8, Núm. 3, pp. 743-753